Does Analysis of the Antigenic Specificities of Anti-Neutrophil Cytoplasmic Antibodies Contribute to Their Clinical Significance in the Inflammatory Bowel Diseases?
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 34 (11) , 1123-1131
- https://doi.org/10.1080/003655299750024931
Abstract
Background: The clinical relevance of anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel diseases is unclear. Definition of their antigenic specificities may improve their diagnostic significance. Methods: We studied the target antigens of ANCA in 96 patients with ulcerative colitis (UC) and 112 patients with Crohn disease (CD) by indirect immunofluorescence, antigen-specific enzyme-linked immunosorbent assays, and immunodetection on Western blot. We related the presence of antibodies of defined specificity to clinical symptoms. Results: By indirect immunofluorescence, ANCA were present in 58% of UC patients and in 21% of CD patients. Major antigens were catalase, alpha-enolase, and lactoferrin. In UC, ANCA titers correlated with disease activity. In CD, both ANCA, by indirect immunofluorescence, and antibodies to lactoferrin were associated with colonic localization of the disease. Neither ANCA, by indirect immunofluorescence, nor antibodies of defined specificity were associated with duration of disease, use of medication, or a history of bowel resection. Conclusions: ANCA are useful as markers for UC and colonic localization in CD. Definition of the antigenic specificities of ANCA in inflammatory bowel disease does not significantly contribute to their clinical significance.Keywords
This publication has 21 references indexed in Scilit:
- Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroupGastroenterology, 1996
- Association of Antineutrophil Cytoplasmic Antibodies With Resistance to Treatment of Left-Sided Ulcerative Colitis: Results of a Pilot StudyMayo Clinic Proceedings, 1996
- Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal diseaseKidney International, 1995
- Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD)Digestive Diseases and Sciences, 1994
- Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlatesClinical and Experimental Immunology, 1994
- Atypical Autoantigen Targets of Perinuclear Antineutrophil Cytoplasm Antibodies (P-ANCA): Specificity and Clinical AssociationsJournal of Autoimmunity, 1993
- Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseasesHepatology, 1993
- A New Type of Perinuclear Anti-Neutrophil Cytoplasmic Antibody (p-ANCA) in Active Ulcerative Colitis but not in Crohn's DiseaseImmunobiology, 1990
- Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.Journal of Clinical Investigation, 1989
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985